Literature DB >> 29418072

Effects of MiR-137 genetic risk score on brain volume and cortical measures in patients with schizophrenia and controls.

Donna Cosgrove1, David O Mothersill1, Laura Whitton1, Denise Harold2, Sinead Kelly3,4, Laurena Holleran1, Jessica Holland1, Richard Anney5,6, Alex Richards7, Kiran Mantripragada7, Michael Owen7, Michael C O'Donovan7, Michael Gill5, Aiden Corvin5, Derek W Morris1, Gary Donohoe1.   

Abstract

Multiple genome-wide association studies of schizophrenia have implicated genetic variants within the gene encoding microRNA-137. As risk variants within or regulated by MIR137 have been implicated in memory performance, we investigated the additive effects of schizophrenia-associated risk variants in genes empirically regulated by MIR137 on brain regions associated with memory function. A polygenic risk score (PRS) was calculated (at a p = 0.05 threshold), using this empirically regulated MIR137 gene set, to investigate associations between this PRS and structural brain measures. These measures included total brain volume, cortical thickness, cortical surface area, and hippocampal volume, in a sample of 216 individuals consisting of healthy participants (n = 171) and patients with psychosis (n = 45). We did not observe a significant association between MIR137 PRS and these cortical thickness, surface area or hippocampal volume measures linked to memory function; a significant association between increasing PRS and decreasing total brain volume, independent of diagnosis status (R2  = 0.008, Beta = -0.09, p = 0.029), was observed. This did not survive correction for multiple testing. In conclusion, our study yielded only suggestive evidence that risk variants interacting with MIR137 impacts on cortical structure.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  GWAS; polygene; psychosis; total brain volume

Mesh:

Substances:

Year:  2018        PMID: 29418072     DOI: 10.1002/ajmg.b.32620

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  3 in total

1.  Polygenic risk for schizophrenia and subcortical brain anatomy in the UK Biobank cohort.

Authors:  Steluta Grama; Isabella Willcocks; John J Hubert; Antonio F Pardiñas; Sophie E Legge; Matthew Bracher-Smith; Georgina E Menzies; Lynsey S Hall; Andrew J Pocklington; Richard J L Anney; Nicholas J Bray; Valentina Escott-Price; Xavier Caseras
Journal:  Transl Psychiatry       Date:  2020-09-09       Impact factor: 6.222

2.  Microglial-expressed genetic risk variants, cognitive function and brain volume in patients with schizophrenia and healthy controls.

Authors:  Emma Corley; Laurena Holleran; Laura Fahey; Aiden Corvin; Derek W Morris; Gary Donohoe
Journal:  Transl Psychiatry       Date:  2021-09-23       Impact factor: 6.222

3.  Cell type-specific and cross-population polygenic risk score analyses of MIR137 gene pathway in schizophrenia.

Authors:  Yin Yao; Wei Guo; Siwei Zhang; Hao Yu; Hao Yan; Hanwen Zhang; Alan R Sanders; Weihua Yue; Jubao Duan
Journal:  iScience       Date:  2021-06-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.